Surveillance study of safety and efficacy of a VWF/FVIII concentrate in patients with von willebrand disease (WIL-20) - a planned interim analysis
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 1, 2015
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Cardiovascular System & Hematology (Science Metrix)